Join Growin Stock Community!
Back to INM.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

revenue-chart

INM Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

Inmed pharmaceuticals inc. (INM) 2026Q2 financial report shows revenue of 820.19K USD, with a YoY growth rate of -26.22%. This clearly indicates that Inmed pharmaceuticals inc. (INM) is facing severe revenue challenges and a significant deterioration. To better understand the business situation, investors are advised to look beyond the revenue YoY, and closely examine trends in net profit, operating profit, and gross margin. In addition, leveraging third-party data such as Growin AI Value Analysis will provide a more comprehensive assessment of the operational pressure and potential financial risks faced by Inmed pharmaceuticals inc. (INM).